Kaelber David C, Liu Weiwei, Ross Michelle, Localio A Russell, Leon Janeen B, Pace Wilson D, Wasserman Richard C, Fiks Alexander G
Comparative Effectiveness Research Through Collaborative Electronic Reporting (CER) Consortium Research Team, Elk Grove Village; Illinois;
Departments of Internal Medicine, Pediatrics, Epidemiology, and Biostatistics, Case Western Reserve University, Cleveland Ohio.
Pediatrics. 2016 Dec;138(6). doi: 10.1542/peds.2016-2195.
Pediatric hypertension predisposes children to adult hypertension and early markers of cardiovascular disease. No large-scale studies have examined diagnosis and initial medication management of pediatric hypertension and prehypertension. The objective of this study was to evaluate diagnosis and initial medication management of pediatric hypertension and prehypertension in primary care.
Retrospective cohort study aggregating electronic health record data on >1.2 million pediatric patients from 196 ambulatory clinics across 27 states. Demographic, diagnosis, blood pressure (BP), height, weight, and medication prescription data extracted. Main outcome measures include proportion of pediatric patients with ≥3 visits with abnormal BPs, documented hypertension and prehypertension diagnoses, and prescribed antihypertensive medications. Marginal standardization via logistic regression produced adjusted diagnosis rates.
Three hundred ninety-eight thousand seventy-nine patients, ages 3 to 18, had ≥3 visits with BP measurements (48.9% girls, 58.6% <10 years old). Of these, 3.3% met criteria for hypertension and 10.1% for prehypertension. Among practices with ≥50 eligible patients, 2813 of 12 138 patients with hypertension (23.2%; 95% confidence interval, 18.2%-28.2%) and 3990 of 38 874 prehypertensive patients (10.2%; 95% confidence interval, 8.2%-12.2%) were diagnosed. Age, weight, height, sex, and number and magnitude of abnormal BPs were associated with diagnosis rates. Of 2813 diagnosed, persistently hypertensive patients, 158 (5.6%) were prescribed antihypertensive medication within 12 months of diagnosis (angiotensin-converting enzyme inhibitors/angiotensin receptive blockers [35%], diuretics [22%], calcium channel blockers [17%], and β-blockers [10%]).
Hypertension and prehypertension were infrequently diagnosed among pediatric patients. Guidelines for diagnosis and initial medication management of abnormal BP in pediatric patients are not routinely followed.
儿童高血压会使儿童易患成人高血压及心血管疾病的早期标志物。尚无大规模研究探讨儿童高血压和高血压前期的诊断及初始药物治疗。本研究的目的是评估初级保健中儿童高血压和高血压前期的诊断及初始药物治疗。
回顾性队列研究,汇总来自27个州196家门诊的120多万名儿科患者的电子健康记录数据。提取人口统计学、诊断、血压(BP)、身高、体重和药物处方数据。主要结局指标包括血压异常且就诊≥3次的儿科患者比例、记录的高血压和高血压前期诊断以及开具的抗高血压药物。通过逻辑回归进行边际标准化得出调整后的诊断率。
398079名3至18岁的患者就诊时测量了血压≥3次(48.9%为女孩,58.6%年龄<10岁)。其中,3.3%符合高血压标准,10.1%符合高血压前期标准。在符合条件患者≥50例的医疗机构中,12138例高血压患者中有2813例(23.2%;95%置信区间,18.2%-28.2%)被诊断,38874例高血压前期患者中有3990例(10.2%;95%置信区间,8.2%-12.2%)被诊断。年龄、体重、身高、性别以及血压异常的次数和幅度与诊断率相关。在2813例确诊为持续性高血压的患者中,158例(5.6%)在诊断后12个月内开具了抗高血压药物(血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂[35%]、利尿剂[22%])。
儿科患者中高血压和高血压前期的诊断并不常见。儿科患者血压异常的诊断和初始药物治疗指南未得到常规遵循。